Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells.
In addition to its effects on macrophage function, macrophage-stimulating protein (MSP) is a growth and motility factor for epithelial cells. The growth and survival of epithelial cells generally require two signals, one generated by interaction with extracellular matrix via integrins, the other initiated by a growth factor. Therefore we investigated the effect of MSP on epithelial cell survival. Survival of epithelial cells cultured overnight in serum-free medium was promoted by adhesion, which activated both the phosphatidylinositol 3'-kinase (PI3-K)/AKT and mitogen-activated protein kinase (MAPK) pathways, operating independently of one another. The number of apoptotic cells resulting from inhibition of either pathway alone was approximately doubled by simultaneous inhibition of both pathways. This shows that each pathway made a partial contribution to the prevention of apoptosis. In the presence of an inhibitor of either pathway, MSP increased the activity of the other pathway so that the single uninhibited pathway alone was sufficient to prevent apoptosis. In contrast to the results with adherent cells, although MSP also prevented apoptosis of cells in suspension (anoikis), its effect was mediated only by the PI3-K/AKT pathway. Despite activation of MAPK by MSP, anoikis was not prevented in suspended cells with a blocked PI3-K/AKT pathway. Thus, activation of MAPK alone is not sufficient to mediate MSP antiapoptotic effects. Cell adhesion generates an additional signal, which is essential for MSP to use MAPK in an antiapoptotic pathway. This may involve translocation of MSP-activated MAPK from the cytoplasm into the nucleus, which occurs only in adherent cells. Our results suggest that there is cross talk between cell matrix adhesion and growth factors in the regulation of cell survival via the MAPK pathway. Growth factors induce MAPK activation, and adhesion mediates MAPK translocation from the cytoplasm into the nucleus.
Danilkovitch
A
A
Immunopathology Section, Laboratory of Immunobiology, National Cancer Institute, Frederick, Maryland, USA. danilkovitch@mail.ncifcrf.gov
Donley
S
S
Skeel
A
A
Leonard
E J
EJ
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002460:Cell Line; D004285:Dogs; D004847:Epithelial Cells / Q000473:pathology / Q000502:physiology*; D006133:Growth Substances / Q000502:physiology*; D017228:Hepatocyte Growth Factor; D020935:MAP Kinase Signaling System; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D011498:Protein Precursors / Q000502:physiology; D011518:Proto-Oncogene Proteins; D015398:Signal Transduction / Q000502:physiology*
D006133:Growth Substances; D011498:Protein Precursors; D011518:Proto-Oncogene Proteins; C082332:macrophage stimulating protein; D017228:Hepatocyte Growth Factor; D019869:Phosphatidylinositol 3-Kinases